Case report: anaphylactic reaction to guaifenesin

Area of Science:

• Immunology
• Pharmacology
• Clinical Medicine

Background:

• Adverse drug reactions are a significant cause of hospital admissions and healthcare costs.
• Allergic responses to medications vary widely, from mild to life-threatening anaphylaxis.
• Predicting and preventing drug allergies remains a challenge in clinical practice.

Observation:

• A young, healthy male experienced a severe anaphylactic reaction after taking an over-the-counter expectorant.
• Diagnostic skin testing confirmed an immunoglobulin E-mediated allergic response to guaifenesin.
• Guaifenesin is a common component in widely available cough and cold medications.

Findings:

• This case represents the first documented instance of a severe allergic reaction specifically attributed to guaifenesin.
• The patient's reaction was confirmed as a Type I hypersensitivity mediated by immunoglobulin E.
• The findings underscore the potential for severe allergic responses to even common pharmaceutical ingredients.

Implications:

• Increased awareness among healthcare providers regarding potential guaifenesin allergy is warranted.
• Further research into the immunological mechanisms of guaifenesin hypersensitivity may aid in risk assessment.
• This case highlights the importance of considering all medication components when investigating adverse drug reactions.